The preeclampsia diagnostics market involves testing diagnosis of preeclampsia in pregnant women. Preeclampsia is a pregnancy complication characterized by high blood pressure and presence of protein in urine after 20 weeks of gestation. It is one of the leading causes of maternal and fetal morbidity and mortality worldwide if not detected and managed timely. Key products in this market include blood pressure monitoring kits, uric acid & urine protein testing kits, abdominal ultrasound devices and other diagnostic tools.

The global preeclampsia diagnostics market is estimated to be valued at US$ 1828.84 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the preeclampsia diagnostics market are The Dow Chemical Company, BASF SE, Covestro A.G., Huntsman Corp., Eastman Chemical Co., Mitsui Chemicals Inc, Recticel S.A., RTP Company Inc., Lubrizol Corp., and Rampf Holding GmbH & Co. KG. These players are focused on developing innovative diagnostic solutions to efficiently detect and manage preeclampsia.

The demand for preeclampsia diagnostic solutions is growing significantly owing to the rising prevalence of the condition globally. As per WHO, preeclampsia complicates approximately 2–8% of pregnancies worldwide. Its timely diagnosis can help reduce adverse outcomes for both mother and fetus.

The global Preeclampsia Diagnostics Market Size is expanding rapidly as key players are focusing on geographical expansion plans especially in developing Asian and Latin American countries. In addition, efforts towards increasing awareness regarding preeclampsia symptoms and importance of its early detection among expectant women are also boosting the market growth.

Market drivers

One of the key drivers of preeclampsia diagnostics market is the growing awareness regarding preeclampsia, its symptoms and importance of early diagnosis among expectant women and caregivers. As per various awareness programs conducted by leading NGOs, government bodies and key market players, it is estimated that early detection of preeclampsia can save lives of over 50,000 mothers and babies annually across the world. This is encouraging more women to opt for timely diagnostic screenings during pregnancy which is fueling the market growth.

Geopolitical Impact on Market Growth

The current geopolitical instability across several regions is impacting the growth of the preeclampsia diagnostics market. The ongoing Russia-Ukraine conflict and economic sanctions have disrupted supply chains and raised input costs. This has made it difficult for diagnostics companies to obtain raw materials and medical devices from these regions. Further, political unrest and regional conflicts in the Middle East have negatively influenced the healthcare sector in affected nations. This has reduced demand for advanced preeclampsia diagnostics. To cope with these challenges, companies need to diversify their supplier networks, look at alternative sourcing options, and focus on expanding in politically more stable markets. They must also try to minimize the effect of rising costs on product prices through operational efficiencies. Continuous monitoring of geopolitical risks and agile long-term strategies will be crucial for sustaining growth in this environment.

Geographical Regions with High Market Concentration

In terms of value, the preeclampsia diagnostics market is currently concentrated in developed regions like North America and Western Europe. This can be attributed to their advanced healthcare infrastructure and widespread access to quality diagnostics services and devices. According to estimates, the United States alone accounted for over 35% of the global market share in 2024 due to the large patient base and favorable reimbursement policies supporting diagnostic product adoption. Other major markets include Germany, the United Kingdom, France, Italy and Spain in Europe. However, with improvement in public healthcare spending and increasing economic capabilities, developing Asian countries like China and India are emerging as new high potential regions.

Fastest Growing Regional Market

The Asia Pacific region is poised to witness the fastest growth in the preeclampsia diagnostics market during the forecast period from 2024 to 2030. This steady expansion can be credited to rising medical awareness, rapid econ0omic development, increasing healthcare expenditure and growing penetration of basic diagnostics tools across countries. Furthermore, improving private healthcare access and expanding healthcare insurance coverage are helping drive up demand. China and India, with their huge population base and scope for further development, present immense untapped growth opportunities. Overall, companies see huge potential for business expansion in Asia Pacific's evolving preeclampsia diagnostics space through regional partnerships and customized product offerings.

Get more insights on- Preeclampsia Diagnostics Market